|
|
 |
|
HKMPDC The First HOKLAS ISO 15189:2012 Accredited Laboratory for Molecular Oncology Testing.
ISO 15189 Accredited Hereditary Cancer Genetic Test:
ISO 15189 Accredited Cancer Biomarker Testing for Precision Medicine (Targeted Therapy):
- Lung Cancer: EGFR (Iressa, Tarceva, Gilotrif), ALK (Xalkori, Zykadia, Alecensa)
- Brain Cancer: MGMT Promoter Methylation, Chromosome 1p and 19q Deletion
- Colon Cancer: KRAS and NRAS (Erbitux, Vectibix), MSI and MMR (PD-L1 Immunotherapy)
- Breast Cancer: HER2 (Herceptin, Perjeta, Kadcyla, Lapatinib)
- Skin Cancer: BRAF (Zelboraf, Tafinlar)
- Ovarian Cancer: BRCA1 and BRCA2 (Lynparza)
|
|
|
|
|
|
|
|
Shipping & Billing Information
|
Non-disclosure and Complaints
All data/information generated from within/related to HKMPDC and our customers are treated in strict confidence in accordance with the Personal Data (Privacy) Ordinance of Hong Kong. If you have a complaint, please contact us at the (852) 2986 1213 or email us at contact@hk-mpdc.com. All communications with HKMPDC would be dealt with in strict confidence.
Notice of Privacy Practices
This notice describes how medical information about you may be used and disclosed.
Personal health information or related information released to HKMPDC relating to the services requested may be subjected to re-disclosure by HKMPDC to health care providers, such as doctors, nurses, and others involved in the delivery of the services.
We may also disclose medical information about you to authorised public health or government officials for public health activities as required by law and accreditation body.
Copyright © 2013 香港分子病理檢驗中心 Hong Kong Molecular Pathology Diagnostic Centre Limited (HKMPDC). All Rights Reserved.
Information Updated 1 July, 2023.
|
|
|
|
